Metoclopramide Cloridrato Noridem

Metoclopramide Hydrochloride, the active ingredient in Metoclopramide Cloridrato Noridem, is a dopamine antagonist / antiemetic presented as an injectable solution for intramuscular and intravenous use. It treats nausea and vomiting, including postoperative, chemotherapy‑induced, and gastroparesis, in adult patients.

GNH USA supplies Metoclopramide Cloridrato Noridem as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metoclopramide acts on the dopaminergic and serotonergic pathways that trigger nausea and delayed gastric emptying. - Nausea and vomiting: reduces frequency and severity of episodes. - Post‑operative nausea and vomiting: prevents and treats symptoms after surgery. - Chemotherapy‑induced nausea: alleviates acute and delayed nausea associated with cancer treatment. - Gastroparesis: enhances gastric motility to improve stomach emptying.

Metoclopramide may cause a range of adverse reactions, from mild to serious.

Common Side Effects: - Drowsiness: mild sedation experienced after administration. - Fatigue: reduced energy levels. - Restlessness: feeling of inner tension or agitation. - Diarrhea: loose, frequent stools.

Serious or Rare Side Effects: - Extrapyramidal symptoms: involuntary muscle movements such as dystonia. - Tardive dyskinesia: persistent facial or tongue movements after prolonged use. - Neuroleptic malignant syndrome: high fever, muscle rigidity, and autonomic instability.

Before using Metoclopramide, consider the following safety measures. - Renal or hepatic impairment: assess organ function prior to initiation. - History of movement disorders: monitor closely for extrapyramidal signs. - Depression or suicidal thoughts: evaluate mental health risk. - Elderly patients: consider lower initial doses. - Known hypersensitivity: avoid use if allergic to the drug. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze.

Metoclopramide can interact with several medication classes.

Major Interactions (Avoid): - Antipsychotics (e.g., haloperidol): increased risk of extrapyramidal symptoms. - CYP2D6 inhibitors (e.g., fluoxetine): elevated plasma concentrations of metoclopramide. - QT‑prolonging drugs: additive risk of cardiac arrhythmias.

Moderate Interactions (Monitor Closely): - Opioids: may enhance anti‑nausea effect but increase sedation. - Sedatives (e.g., benzodiazepines): heightened drowsiness. - Anticholinergics: possible reduction of pro‑kinetic activity.